Peglow Sheree L MD is categorized under Infectious Disease Specialists in South Bend, IN and active since 2001.
Peglow Sheree L MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sheree Peglow at the company’s single location by writing to 707 North Michigan St # 314, South Bend, Indiana IN 46601 or by phoning (574) 234-5938. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Peglow Sheree L MD |
| Contact Person: | Sheree Peglow |
| Address: | 707 North Michigan St # 314, South Bend, Indiana 46601 |
| Phone Number: | (574) 234-5938 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Peglow Sheree L MD was started in 2001 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Sheree Peglow for inquiries that concern Peglow Sheree L MD by calling the company number (574) 234-5938, as your correspondence is most welcome. Additionally, the physical location of the single location of Peglow Sheree L MD can be found at the coordinates 41.68411,-86.25062 as well as the street address 707 North Michigan St # 314 in South Bend, Indiana 46601.
For its online presence, you may visit Peglow Sheree L MD’s website at and engage with its social media outlets through on Twitter and on Facebook.